THROMBECTOMY DEVICES MARKET ANALYSIS

Thrombectomy Devices MarketSize and Trends

Global thrombectomy devices market is estimated to be valued at US$ 1.68 Bn in 2023, and is expected to exhibit a CAGR of 7.5% during the forecast period (2023-2030).

Thrombectomy devices are used in thrombectomy process. Mechanical thrombectomy devices comprise of a wide array of endovascular tools taht removes thrombi from the neurovasculature in acute ischemic stroke patients. Rising number of patient population with a deep vein thrombosis, pulmonary embolism, and renal vein thrombosis are expected to increase the number of thrombectomy procedures. Thus, it offers the opportunity to various manufacturers to offer various thrombectomy devices such as mechanical thrombectomy and aspiration thrombectomy devices that allows surgeons to perform such surgeries more efficiently.

Figure 1. Global Thrombectomy Devices Market Share (%), By Product Type, 2023

Global Thrombectomy Devices Market- Segmentation

Global thrombectomy devices market  is segmented into product type, application, end user, and region.

• Based on product type, the market is segmented into mechanical thrombectomy devices, aspiration thrombectomy devices, hydrodynamic thrombectomy devices, and ultrasonic thrombectomy devices. Out of which, the mechanical thrombectomy devices segment is expected to hold a dominant position in the global thrombectomy devices market during the forecast period due to increasing product launches by key market players.
• Based on application, the market is segmented into deep vein thrombosis (DVT), pulmonary embolism (PE), superficial vein thrombosis, reneal vein thrombosis (RVT), arterial thrombosis (Atherothrombosis), and Others (Ischemic Stroke, etc.). Out of which, deep vein thrombosis (VBT) segment  is expected to dominate the market over the forecast period due  to increasing prevalence of deep vein thrombosis.
• Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and Others (Academic and Research Institutes, etc.). Out of which, the hospitals segment is expected to dominate the market over the forecast period due to increasing number of hospitals for thrombectomy process.
• Among all the segmentation, the application segment is expected to dominate the market over the forecast period due to increasing prevalence of deep vein thrombosis and pulmonary embolism

Global Thrombectomy Devices Market- Cross Sectional Analysis

Among application segment deep vein thrombosis is expected to drive the global thrombectomy devices market over the forecast period due to increasing adoption of inorganic strategies such as launch of campaigns, in order to raise awareness about deep vein thrombosis. For instance, in November 2020, The Bristol Myers Squibb, biopharmaceutical company and Pfizer Inc., pharmaceutical company, Alliance, announced the launch of ‘No Time to Wait’ awareness campaign, to raise awareness about symptoms of deep vein thrombosis. This campaign helps people to find additional information about deep vein thrombosis.